Keywords: GC-MS; Gas chromatography-mass spectrometry; LC-MS/MS; Liquid chromatography tandem mass spectrometry; TD-ESI-MS; Thermal desorption-electrospray ionization-mass spectrometry; MDMA; 3,4-methylenedioxymethamphetamine; MDA; 3,4-methylenedioxyamphetamine;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MDMA; Ecstasy; Market; Europe; EMCDDA;
Keywords: ATS; amphetamine-type stimulants; AM; amphetamine; CE; collision energies; DLLME; dispersive liquid-liquid extraction; GC; gas chromatography; HS-SPME; head-space microextraction; IT/MS; ion trap mass spectrometry; LC; liquid chromatography; LC-UV; liquid
Keywords: Methamphetamine; MDMA; Neurocognition; Youth mental health;
Keywords: Nordic countries; Wastewater-based epidemiology; Amphetamine; Methamphetamine; MDMA; Cocaine;
Keywords: Aβ; amyloid beta; AβO; Aβ oligomer; ACh; acetylcholine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AGEs; advanced glycation end products; AND; age-related neurological disorder; Bax; Bcl-2-associated X protein; Bcl-2; B-cell lymphoma 2; BDNF;
Keywords: AC927; 1-(2-phenylethyl)piperidine; AMPH; amphetamine; ATS; amphetamine-type stimulants; AZ66; 3-(4-(4-cyclohexylpiperazin-1-yl)pentyl)-6-flourobenzo(Abadias et al., 2013)thiazol-2(3H)-one; BD1008; N-(Brammer et al., 2006)-N-methyl-1-pyrrolidineethanamine
Keywords: LC-MS/MS; liquid chromatography-tandem mass spectrometry; MDMA; 3,4-methylenedioxymethamphetamine; MDEA; 3,4-methylenedioxy-N-ethylamphetamine; MDA; 3,4-methylenedioxyamphetamine; sMRM; scheduled multiple reaction monitoring; CLSM; Confocal Laser Scanning
Keywords: DAB; 3,3â²âdiaminobenzidine; DG; dentate gyrus; HRP; horseradish peroxidase; MDMA; 3, 4âmethylenedioxymethamphetamine; Apoptosis; Memory; Mephedrone; Mice; Pregnancy; Stillbirth;
Keywords: Mephedrone; New psychoactive substances; Monoamine; Receptors; Transporters; 2,3-DMMC; 2,3-dimethylmethcathinone; 2,4-DMMC; 2,4-dimethylmethcathinone; 3,4-DMMC; 3,4-dimethylmethcathinone; 3-MMC; 3-methylmethcathinone; 4-MA; 4-methylamphetamine; 4-MMC; 4-m
Keywords: Granule cell neurons; Hippocampus; Ki-67; NeuroD1; MDMA; Methamphetamine;
Keywords: ATS; amphetamine-type stimulants; CNS; central nervous system; DFC; drug-facilitated crime; DFSA; drug-facilitated sexual assault; GABA; gamma aminobutyric acid; GHB; gamma hydroxybutyric acid; GBL; gamma butyrolactone; MDA; 3,4-methylenedioxyamphetamine;
Keywords: MDMA; 3,4-methylenedioxymethamphetamine; MDAI; 5,6-methylenedioxy-2-aminoindane; API; active pharmaceutical ingredient; ANFO; ammonium nitrate fuel oil; ANN; artificial neural network; CTAB; cetyltrimethylammonium bromide; CCD; charge-coupled device; CCSW
Keywords: Ach; acetylcholine; ADHD; attention-deficit hyperactivity disorder; BDNF; brain-derived neurotrophic factor; BEND; beta-endorphin; BFNA; beta-funaltrexamine; Ca(2+); calcium; CAMK; calmodulin-dependent protein kinase II; cAMP; cyclic adenosine monophospha
Keywords: MDMA; New psychoactive substances; Synthetic cathinones; Hair-testing; Adulterants;
Keywords: ADP; adenosine-diphosphate; AK; adenylate kinase; BSO; buthionine sulfoximine; CYP; cytochrome P450; DMEM; Dulbecco's Modified Eagle Medium; DTNB; 5,5â²-dithio-bis(2-nitrobenzoic acid); FCCP; trifluoromethoxy carbonylcyanide phenylhydrazone; FCS; fetal
Keywords: Heat stroke; Drug abuse; MDMA; Disseminated intravascular coagulation;
Keywords: BMP15; bone morphogenetic protein 15; BPA; bisphenol-A; COC; cumulus cell-oocyte complex; GDF9; growth differentiation factor 9; MDMA; 3,4-methylenedioxymethamphetamine; THC; Î9-tetrahydrocannabinol; Oocyte; Cumulus cells; Gap junctions; Oocyte growth fa
Keywords: Critical care; Substance-related disorders; Opioid-related disorders; Stimulant-related disorders; Synthetic cannabinoid; Synthetic cathinone; Cocaine; MDMA;
Keywords: 2-AI; 2-aminoindane; 2C-B; 2,5-dimethoxy-4-bromophenethylamine; 5-IAI; 5-iodo-2-aminoindane; COMT; catechol-O-methyl transferase; CPP; conditioned place preference; DAT; dopamine transporter; DIO; diet-induced obese; DMT; N,N-dimethyltryptamine; EAAT2; ex
Keywords: Dopamine; Ecstasy; Methamphetamine; METH; 3,4-Methylenedioxymethamphetamine; MDMA; Mouse; Neurodegeneration; Neuroinflammation neurotoxicity; Non-human primate; Rat; AC; adenylyl cyclase; AcbSh; nucleus accumbens shell; AcbC; nucleus accumbens core; cAMP;
Keywords: Suspected drug users; Illicit drugs; Stimulant designer drugs; Biological samples; Seizure data; Mephedrone (4-MMC); 4-methylmetcathinone, 2-(methylamino)-1-(4-methylphenyl)propan-1-one; 3-FA; 3-fluoro-amphetamine, 1-(3-fluorophenyl)propan-2-amine; 4-FA;
Keywords: Ecstasy; MDMA; Adolescents; Underreporting;
Keywords: MDMA; 3,4-methylenedioxymethamphetamine; NE; norepinephrine; FFA; free fatty acids; CNS; central nervous system; DEA; Drug Enforcement Administration; DA; dopamine; 5HT; serotonin; NET; norepinephrine transporter; DAT; dopamine transporter; SERT; serotoni
Keywords: Solid sensors; Amphetamines; MDMA; Ecstasy; Street samples; In-situ analysis;
Keywords: LOD; limit of detection; LOQ; limit of quantification; KM; Kaplan-Meier estimate; MLE; Maximum Likelihood Estimation; WWTP; wastewater treatment plant; ACS; American Community Survey; RSD; relative standard deviation; MDMA; 3,4 methylenedioxymethamphetami
Keywords: Hallucinogen; LSD; MDMA; Psilocybin; PCP; Adolescent; Treatment;
Keywords: L; Dopa (levedopa); MAO; inhibitors (monoamine oxidase B); COMPT; inhibitors (catechol-o-methyl transferase); MPTP; (1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine); MPPP; (1-Methyl-4-phenyl-4-propionoxypiperidine); MPDP; (1-Methyl-4-phenyl-1, 2-dihydrox
Keywords: Adolescence; MDMA; Methamphetamine; D-Amphetamine; Hippocampus; Neurogenesis
Keywords: Alcohol abuse; caffeine; tobacco smoking; drug abuse; bruxism; review literature; CNS; Central nervous system; EMG; Electromyography; LILACS; Latin American and Caribbean Health Sciences Literature; MAStARI; Meta-Analysis of Statistics Assessment and Revi
Keywords: 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; ALP; alprazolam; AM; amphetamine; ATC; Anatomical Therapeutic Classification; ATS; amphetamine-type stimulant; BE; benzoylecgonine; BQ; benchmark quotient; BW; body weight; CAF; caffeine; CBD; cannabid
Keywords: Adolescent; Affect; Alcohol; Animal models; Brain; Cannabinoids; Cocaine; Cognition; Ethanol; MDMA; Methamphetamine; Nicotine; Rat;
Keywords: 5-HIAA; 5-hydroxyindoleacetic acid; ASD; autism spectrum disorder; ITGB3; integrin β3 subunit gene; MAOA; mitochondrial bound protein monoamine oxidase A; MAPK; mitogen-activated protein kinase; MDMA; 3,4-methylenedioxymethamphetamine; NAS; N-acetylserot
Keywords: Ecstasy; MDMA; Serotonin; SERT; PET; SPECT; Meta-analysis; Molecular imaging;
Keywords: Forensic science; Comprehensive two-dimensional gas chromatography; Mass spectrometry; GCâÃâGC; GCâÃâGC-MS; Data analysis; Review; 1D; One dimensional; 2D; Two dimensional; 3D; Three dimensional; AAS; Atomic absorption spectrometry; ANOVA; Ana
Keywords: addiction; pharmacology; neurobiology; animal models; social impact; GABA; gamma-aminobutyric acid; LSD; lysergic acid diethylamide; MDMA; methylenedioxymethamphetamine;
Keywords: Wastewater analysis; Surveys; Methamphetamine; 3,4-Methylenedioxymethamphetamine; MDMA; Cocaine;
Keywords: Complex I; Dopamine; MDMA; Mitochondria; Oxidative stress; AMPT; α-methyl-p-tyrosine; DA; dopamine; MAO; monoamine oxidase; MDMA; 3,4-methylenedioxymethamphetamine; TH; L-tyrosine hydroxylase; ROS; reactive oxygen species;
Keywords: Monoamine transporters; Neurotransmitter transport; Stimulants; Serotonin; MDMA; Excitability; L-type Ca2+ channels;
Keywords: nouvelles drogues; phénéthylamines substituées; cathinones substituées; méthoxétamine; cannabinoïdes de synthèse; 4-FA; 4-fluoroamphétamine; 4-MA; 4-méthylamphétamine; CB1; récepteurs cannabinoïdes de type 1; CS; cannabinoïdes de synthèse;
Keywords: MA; methamphetamine; AMP; amphetamine; MDMA; methylendioxymethamphetamine; Amphetamine; Methylendioxymethamphetamine; Methamphetamine; Pregnancy; Animal model; Neurodevelopment;
Keywords: 3D; three-dimensional; c log P; the calculated log octanol/water partition coefficient; DNA; deoxyribonucleic acid; ATP; adenosine triphosphate; HPT1; intestinal peptide-associated transporter 1; PEPT1; peptide transporter 1; OCT; organic cation transpo
Keywords: [123I]-β-CIT; 123I-labelled 2b-carbomethoxy-3b-(4-iodophenyl) tropane; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-hydroxytryptamine, serotonin; 5-HTT; serotonin transporter; ADHD; attention deficit hyperactivity disorder; AMPH; amphetamine; ATS; ampheta
Keywords: Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: Mephedrone; Methamphetamine; MDMA; Serotonin; Bath salts; Neurotoxicity
Keywords: 6ACM; 6-acetylmorphine; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulants; BE; benzoylecgonine; CE; cocaethylene; CO; cocaine; DAs; drugs of abuse; DIA; diazepam; EDDP; 2-ethylene-1,5-dimethyl-3,3-diphenylpyrrolidine; EPs; emerging pollut
Keywords: aCSF; artificial cerebrospinal fluid; MDMA; 3,4-methylenedioxy-N-methylamphetamine; HEK; human embryonic kidney; ACMD; Advisory Council on the Misuse of Drugs; FCV; fast cyclic voltammetry; ANOVA; analysis of variance; DAT; dopamine transporter; NET; nora
Keywords: CLIA; Clinical Laboratory Improvement Amendments; ED; emergency department; EG; ethylene glycol; HPLC; high pressure (performance) liquid chromatography; POCT; point-of-care testing; TAT; turnaround time; UDT; urine drug testing; MDMA; 3,4-methylenedioxym
Keywords: Addiction; Amphetamine; Central stimulants; Cocaine; Cognition; MDMA; Neuroplasticity;
Keywords: Oxytocin; Vasopressin; Mood; MDMA; Pre-clinical; Review;